Encompass Health/EHC

$82.39

2.56%
-
1D1W1MYTD1YMAX

About Encompass Health

Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides specialized rehabilitative treatment on an inpatient basis. It operates hospitals in 37 states and Puerto Rico, with concentrations in Florida and Texas. It operates 161 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. The Company provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals also treat patients with or recovering from the COVID-19 virus. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.

Ticker

EHC

Sector

Healthcare

Trading on

NYSE

Industry

Healthcare Facilities

CEO

Mark Tarr

Employees

22,356

Headquarters

Birmingham, United States

Encompass Health Metrics

BasicAdvanced
$7.93B
Market cap
22.96
P/E ratio
$3.45
EPS
0.94
Beta
$0.60
Dividend rate
0.76%
Dividend yield
$7.93B
0.9428
$83.73
$57.55
670.84K
$0.60
1.282
163.144
164.65
16.79%
106.511
5.29%
8.09%
24.45%
10.21%
22.959
1.652
4.821
90.149
38.269
1.6%
0.76%
0.76%
10.41%
40.15%
10.42%
22.27%
-18.78%

What the Analysts think about Encompass Health

Analyst Ratings

Majority rating from 11 analysts.
Buy

Price Targets

Average projection from 10 analysts.
8.27% upside
High $101.00
Low $83.00
$82.39
Current price
$89.20
Average price target

Encompass Health Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
7.02% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$1.25B
3.31%
Net income
$87.6M
2.7%
Profit margin
7.02%
-0.57%

Encompass Health Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 16.42%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.88
$0.95
$0.86
$0.95
-
Expected
$0.70
$0.75
$0.77
$0.82
$0.94
Surprise
25.15%
27.5%
11.83%
16.42%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Encompass Health stock?

Encompass Health (EHC) has a market cap of $7.93B as of April 23, 2024.

What is the P/E ratio for Encompass Health stock?

The price to earnings (P/E) ratio for Encompass Health (EHC) stock is 22.96 as of April 23, 2024.

Does Encompass Health stock pay dividends?

Yes, the Encompass Health (EHC) stock pays dividends to shareholders. As of April 23, 2024, the dividend rate is $0.6 and the yield is 0.76%. Encompass Health has a payout ratio of 16.79% on a trailing twelve-month basis.

When is the next Encompass Health dividend payment date?

The next Encompass Health (EHC) dividend payment date is unconfirmed.

What is the beta indicator for Encompass Health?

Encompass Health (EHC) has a beta rating of 0.94. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Encompass Health stock price target?

The target price for Encompass Health (EHC) stock is $89.2, which is 8.27% above the current price of $82.39. This is an average based on projections from 10 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Encompass Health stock

Buy or sell Encompass Health stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing